Enanta Pharmaceuticals Inc (NASDAQ:ENTA)

37.14
Delayed Data
As of Apr 24
 +0.56 / +1.53%
Today’s Change
30.13
Today|||52-Week Range
52.58
-26.96%
Year-to-Date

Today’s Trading

Previous close36.58
Today’s open36.30
Day’s range36.17 - 37.99
Volume254,387
Average volume (3 months)351,069
Market cap$693.8M
Dividend yield--
Data as of 3:59pm ET, 04/24/2015

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+197.35%
Earnings growth (next 5 years)--
Revenue growth (last year)+48.94%
P/E ratio8.9
Price/Sales19.55
Price/Book4.65

Competitors

 Today’s
change
Today’s
% change
VTLVital Therapies Inc+0.19+0.65%
AMPHAmphastar Pharmaceut...-0.04-0.26%
CORTCorcept Therapeutics...-0.12-1.86%
INFIInfinity Pharmaceuti...-0.11-0.75%
Data as of 3:59pm ET, 04/24/2015

Financials

Next reporting dateMay 6, 2015
EPS forecast (this quarter)$1.74
Annual revenue (last year)$47.7M
Annual profit (last year)$34.4M
Net profit margin72.14%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Jay R. Luly
Chief Financial Officer &
Senior VP-Administration
Paul J. Mellett
Corporate headquarters
Watertown, Massachusetts

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers